Back
Mullen Group Vs. Bright Minds Biosciences Industry Stock Comparison
Sell
30
MTL.TO
Mullen Group
Last Price:
14.41
Seasonality Move:
0.85%
Sell
50
DRUG
Bright Minds Biosciences
Last Price:
70.42
Seasonality Move:
-16.97%
Sell
30
Mullen Group (MTL.TO)
is a Sell
Is Mullen Group a Buy, Sell or Hold?
- The current Mullen Group [MTL.TO] share price is $14.55. The Score for MTL.TO is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- MTL.TO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
Bright Minds Biosciences (DRUG)
is a Sell
Is Bright Minds Biosciences a Buy, Sell or Hold?
- The current Bright Minds Biosciences [DRUG] share price is $28.80. The Score for DRUG is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- DRUG is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MTL.TO Stock Price Chart
What is Mullen Group's stock price today?
-
The Mullen Group share price today is $14.55
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MTL.TO is experiencing selling pressure, which indicates risk of future bearish movement.
DRUG Stock Price Chart
What is Bright Minds Biosciences's stock price today?
-
The Bright Minds Biosciences share price today is $28.80
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRUG is experiencing slight buying pressure.
MTL.TO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.07 | Buy |
Relative Strength Index (14 RSI): | 57.95 | Buy |
Chaikin Money Flow: | -71106 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.13 - 14.47) | Buy |
Bollinger Bands (100): | (13.1 - 14.48) | Buy |
DRUG Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.5 | Buy |
Relative Strength Index (14 RSI): | 77.84 | Buy |
Chaikin Money Flow: | 92732 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (-4.96 - 12.54) | Buy |
Bollinger Bands (100): | (-2.76 - 6.3) | Buy |
MTL.TO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14.4 | Buy |
20-day SMA: | 14.34 | Buy |
50-day SMA: | 14.29 | Buy |
200-day SMA: | 14.07 | Buy |
8-day EMA: | 14.44 | Buy |
20-day EMA: | 14.34 | Buy |
50-day EMA: | 14.21 | Buy |
200-day EMA: | 14.02 | Buy |
DRUG Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 9.28 | Buy |
20-day SMA: | 4.42 | Buy |
50-day SMA: | 2.44 | Buy |
200-day SMA: | 1.64 | Buy |
8-day EMA: | 13.74 | Buy |
20-day EMA: | 7.01 | Buy |
50-day EMA: | 3.65 | Buy |
200-day EMA: | 2.03 | Buy |
Mullen Group Earnings Growth & MTL.TO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.14 per share, and an increase next year of $0.10 per share.
Bright Minds Biosciences Earnings Growth & DRUG Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Mullen Group Technical Analysis
Oct 2 | Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 15 | Oct 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
02 | 03 | 04 | 07 | 08 | 09 | 10 | 11 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Bright Minds Biosciences Technical Analysis
Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |